Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $214.20 | Total: $1,071.00 |
| 1 | 10 | $181.44 | Total: $1,814.40 |
| 1 | 25 | $153.72 | Total: $3,843.00 |
| 1 | 50 | $131.04 | Total: $6,552.00 |
| 1 | 100 | $113.40 | Total: $11,340.01 |
Overview
HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor (IC50: 10.5 nM) that also inhibits PIM123, RIPK2, DYRK3, smMLCK, and CLK2. It can be used to study breast cancer.
Chemical Properties
| Molecular Formula | C26H28Cl2N4O2 |
| Molecular Weight | 499.43 |
| CAS Numbers | 2000209-42-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1N(C2=C3C(=NC=C2CN1)C=CC(=C3)C4=CC(Cl)=C(O)C(Cl)=C4)[C@@H]5CC[C@@H](CN(C)C)CC5 |
Storage and Handling
0C Short Term, -20C Long Term
References
Huang HT, et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. Elife. 2017;6 e26693.